Thermal spa for Primary Ciliary Dyskinesia (PCD)
Part of Ear, nose & throat, Genetic & congenital, Lungs & breathing clinical trials.
This trial tests whether a stay at a thermal spa can improve symptoms of Primary Ciliary Dyskinesia (PCD), a genetic lung condition. It's for adults with stable PCD who haven't had a recent infection or spa treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old.
- You have a confirmed diagnosis of Primary Ciliary Dyskinesia (PCD) from a genetic test or cilia exam.
- Your treatment has been stable for at least one month before starting the study.
- You haven't had a thermal spa treatment in the past year.
- You don't have a recent lung, sinus, or ear infection, and no serious health problems like heart failure or recent cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the airways in people with primary ciliary dyskinesia (PCD) react to certain triggers. It aims to understand if these airways are more sensitive, which could help improve treatment for breathing problems.
This study tests whether a breathing test called nasal nitric oxide can help improve care for people with primary ciliary dyskinesia (PCD) or related lung/sinus problems. The goal is to see if the test can better guide diagnosis and treatment planning.
This trial tests whether a combination of glycine, magnesium, and thiamine can help people with primary ciliary dyskinesia (a condition that affects the tiny hairs in your lungs). It aims to see if these supplements improve breathing and reduce lung problems.
This study looks at how chest physiotherapy affects lung function in people with primary ciliary dyskinesia (a lifelong condition affecting mucus movement in the lungs). It may help care teams understand which breathing therapies work best and how your lungs respond.
This registry study collects medical information and samples from children who may have or have been diagnosed with primary ciliary dyskinesia (PCD). It helps researchers better describe the condition and its causes in Chinese children.
This study tests an inhaled medication (hypertonic saline) to see if it helps clear mucus from the lungs of people with Primary Ciliary Dyskinesia (PCD). It involves exercise testing and regular lung function checks.
Hear when a new Primary Ciliary Dyskinesia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.